Francisco Moya - Academia.edu (original) (raw)
Papers by Francisco Moya
Journal of Clinical Oncology, 2009
The aim of this work was to assess immunologic response, disease progression, and posttreatment s... more The aim of this work was to assess immunologic response, disease progression, and posttreatment survival of melanoma patients vaccinated with autologous dendritic cells (DCs) pulsed with a novel allogeneic cell lysate (TRIMEL) derived from three melanoma cell lines.
Journal of Clinical Oncology, 2009
The aim of this work was to assess immunologic response, disease progression, and posttreatment s... more The aim of this work was to assess immunologic response, disease progression, and posttreatment survival of melanoma patients vaccinated with autologous dendritic cells (DCs) pulsed with a novel allogeneic cell lysate (TRIMEL) derived from three melanoma cell lines.